Webbför 11 timmar sedan · ResMed shares are up about 8.5% this year, slightly outperforming the S & P 500. Over the past year, though, it's down more than 3%. — CNBC's Michael Bloom contributed to this report. WebbFör 1 dag sedan · ResMed shares are selling on the expensive side of a fair value but the numbers and growth potential make us bullish on the stock. Fundamentals are strong …
Michael J. Farrell Sells 5,675 Shares of ResMed Inc. (NYSE:RMD) …
Webb14 apr. 2024 · Allspring Global Investments Holdings LLC decreased its holdings in shares of ResMed Inc. (NYSE:RMD - Get Rating) by 34.3% in the 4th quarter, according to the … Webb14 apr. 2024 · JPMorgan Chase & Co. boosted their target price on shares of ResMed from $245.00 to $260.00 and gave the stock an “overweight” rating in a research report on … check att texts online
Mizuho Initiates Coverage of ResMed (RMD) with Buy …
Webb14 apr. 2024 · In other ResMed news, COO Robert Andrew Douglas sold 1,500 shares of ResMed stock in a transaction that occurred on Tuesday, January 17th. The stock was sold at an average price of $220.43, for a total value of $330,645.00. Following the completion of the sale, the chief operating officer now directly owns 226,208 shares in the company, … WebbResmed Inc. (RMD) is a global company digital health and cloud-connected medical devices. The Company design innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Also, its digital health technologies and cloud-connected medical devices transform care for people with sleep ... WebbResMed shares (RMD) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. ResMed has a trailing 12-month revenue of around $3.8 billion. … check attribute python